Holen Sie sich die Stockscreener-App
30.49
2.15%
-0.67
Handel nachbörslich:
30.49
Schlusskurs vom Vortag:
$31.16
Offen:
$31.03
24-Stunden-Volumen:
902.91K
Relative Volume:
1.62
Marktkapitalisierung:
$1.44B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-66.28
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
-1.13%
1M Leistung:
-6.73%
6M Leistung:
-38.78%
1J Leistung:
+1.19%
1-Tages-Spanne:
$30.36
$31.03
1-Wochen-Bereich:
$30.36
$32.18
52-Wochen-Spanne:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
30.49 | 1.44B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
236.99 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.07 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.42 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.98 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Multifunctional Intravenous Drug Dispensing Robot Market - openPR.com
Central Fill Pharmacy Automation Market Is Booming So - openPR.com
Central Fill Pharmacy Automation Market Set to Witness - openPR.com
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance
Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks - The Globe and Mail
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - Nasdaq
Investors in Omnicell (NASDAQ:OMCL) have unfortunately lost 75% over the last three years - Yahoo Finance
Future-Proofing Growth of Smart Pharmacy Dispensing System - openPR.com
Wells Fargo Adjusts Omnicell (OMCL) Price Target Amid Cost Concerns | OMCL Stock News - GuruFocus
Global Preventive Healthcare Technologies And Services Market - openPR.com
Pharmacy Automation Market Is Booming So Rapidly 2025-2032 - openPR.com
Lobbying Update: $50,000 of OMNICELL lobbying was just disclosed - Nasdaq
Pharmacy Automation Systems Market May Set New Growth Story | McKesson, Omnicell, Baxter International - openPR.com
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 | OMCL Stock News - GuruFocus
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 - BioSpace
Pharmacy Automation System Market is Expected to reach US$ 11.21 - openPR.com
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Here's Why Omnicell (OMCL) is a Strong Value Stock - Yahoo Finance
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Omnicell (OMCL): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Omnicell (NASDAQ:OMCL) Seems To Use Debt Rather Sparingly - simplywall.st
Central Fill Pharmacy Automation Market to Witness Massive - openPR.com
Pharmacy Automation Market to Witness Remarkable Growth with - openPR.com
Consolidation at Omnicell - Pharmacy Magazine
India Pharmacy Automation Market Competition, Forecast & Opportunities Report 2025 Featuring Becton Dickinson, Omnicell, Baxter International, Cerner, and TouchPoint - GlobeNewswire
Omnicell Names Veteran Surgical Robotics Exec as Its New CTO - Dallas Innovates
Omnicell Appoints New CTO to Drive Technological Innovation - Zenopa
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - EnterpriseTalk
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):